Raxibacumab is a monoclonal antibody used alongside antibacterial regimens for treating inhalational anthrax caused by Bacillus anthracis and for preventive treatment when necessary. The DrugMonitor™ Anti-Raxibacumab Antibody (VS-1224-YC984) is an anti-drug antibody (ADA) against Raxibacumab. This drug-based antibody is raised in mice immunized with the Raxibacumab. The anti-Raxibacumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Raxibacumab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Anti-B. Anthracis Anthrax Protective Antigen (Raxibacumab)Recombinant monoclonal antibody to Bacillus anthracis protective antigen. Raxibacumab is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax. Its efficacy has been proven in rabbits and monkeys.
Afuco™ Anti-B. anthracis PA ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-224)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Bacillus anthracis protective antigen. It is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax. Its efficacy has been proven in rabbits and monkeys.
There are currently no Customer reviews or questions for VS-1224-YC984. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.